China (Mainland)
Assessedsupplier
Tianfu Chem Eptifibatide CAS NO.148031-34-9
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T,MoneyGram
- Product Details
Keywords
- Eptifibatide
- Eptifibatide
- 148031-34-9
Quick Details
- ProName: Tianfu Chem Eptifibatide
- CasNo: 148031-34-9
- Molecular Formula: C35H49N11O9S2
- Appearance: white powder
- Application: For Organic Synthesis use
- DeliveryTime: Prompt
- PackAge: As per buyers'
- Port: SHANGHAI,PORT
- ProductionCapacity: 10 Metric Ton/Month
- Purity: 99.0%Min
- Storage: In Room Temperature
- Transportation: by sea or air
- LimitNum: 1 Kilogram
- Heavy metal: N/M
- Grade: Industrial Grade,Food Grade,Pharma Gra...
- N/M: N/M
Superiority
Product Name: Eptifibatide
Synonyms: INTEGRELIN;EPTIFIBATIDE ACETATE;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;Mpr-Harg-Gly-Asp-Trp-Pro-Cys-NH2,( Disulfide Bridge:1-7);Eptifibatide;Human Eptifibatide;Eptifitide;Mpr-Harg-Gly-Asp-Trp-Pro-Cys-NH2,( Disulfide Bridg on Mpr and Cys)
CAS: 148031-34-9
MF: C35H49N11O9S2
MW: 831.96
EINECS: 1533716-785-6
Product Categories: Amino Acid Derivatives;Peptide;proteins
Mol File: 148031-34-9.mol
Eptifibatide Structure
Eptifibatide Chemical Properties
CAS DataBase Reference 148031-34-9(CAS DataBase Reference)
Safety Information
MSDS Information
Eptifibatide Usage And Synthesis
Pharmacological effects Eptifibatide is a platelet glycoprotein Ⅱb/Ⅲa receptor reversible antagonist,adverse reactions are mild , it can be discontinued immediately while adverse reactions occur . It has Strong effect and high selectivity . It has no antigenicity,and it does not cause allergic reactions. It is used For acute coronary syndrome, coronary intervention before treatment and acute Q-wave myocardial infarction. It can relieve unstable angina symptoms and reduce the incidence of cardiovascular events. It can limit the non-Q-wave myocardial infarction,and reduce through wall myocardial infarction occurrance.
Eptifibatide is used to treat acute coronary syndrome, the starting amount is 180μg/kg, the intravenous maintenance dose is per minute 2μg/kg continuous intravenous infusion 72h, if implementing the primary percutaneous coronary intervention, continuous intravenous drip after surgery is 18~24h. For percutaneous coronary intervention, the starting amount is 180μg/kg intravenous injection, after 2μg/kg continuous intravenous infusion every minute, after 10 min, administrated again with 180μg/kg intravenously per minute , thereafter 2μg/kg continuous intravenous infusion for 18~24h.
Details
Our company was built in 2009 with an ISO certificate.In the past 5 years, we have grown up as a famous fine chemicals supplier in China
and we had established stable business relationships with Samsung,LG,Merck,Thermo Fisher Scientific and so on.
Our advantage:
1.Higest quality and good package
2.Fast delivery
3.Better payment term
4.Fast response to customer within 6 hours
5.Good business credit in Europe ,US ,Japan ,Korea
